View All ETFs

PINK

Simplify Health Care ETF

Spotlight Banner
As of 11/12/2025

NAV

$ 34.81

NAV Change

+ $ 0.42 /1.22%

Price

$ 34.79

Price Change

+ $ 0.35 /1.02%

The Simplify Health Care ETF (PINK) seeks long term capital appreciation by providing investors with multi-cap exposure to groundbreaking and innovative companies in biotech, medtech, gene therapy, and other fast growing health care related sectors.

Michael Taylor serves as lead portfolio manager of the ETF and brings over two decades of experience managing long/short health care equity portfolios at leading hedge funds. PINK is the first 100% pro bono ETF focused on the health care sector and net profits will be donated for the benefit of the Susan G. Komen foundation on an annual basis.

PINK: Shares for the Cure Find out more.

Susan's Logo
Donations

$350,000

as of 09/01/25

Spotlight Banner

Documents

Why Health Care Now: Enhancing the 60/40 Portfolio with Active Management

Read Article

PINK Overview

PINK Fund Deep Dive Live

Fund Overview

As of 11/12/2025

Ticker Symbol
PINK
Gross Expense Ratio
0.51%
CUSIP
82889N772
Total Assets
$263,705,264.08
Shares Outstanding
7,575,001
Distribution Rate as of 09/30/2025 Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.
Distribution Rate Close
Distribution rate calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution rate.
0.63%
Distribution Frequency
Quarterly
30-Day SEC Yield (Subsidized) as of 09/30/2025
-
30-Day SEC Yield (Unsubsidized) as of 09/30/2025
0.40%
Options Available
Yes
Inception Date
10/07/2021
Premium/Discount (%) as of 11/12/2025
-0.06%
NAV Per Share as of 11/12/2025
$34.81
Market Price as of 11/12/2025
$34.79
30-Day Median Bid-Ask Spread
0.15%
Bid/Ask
$34.82/$34.87
Midpoint Price
$34.85
Volume
239,473
NAV Symbol
PINK.NV
IOPV Symbol
PINK.IV
Shares Out. Symbol
PINK.SO
Schedule K-1
No
 
The Distribution Rate is the annual rate an investor would receive if the most recently declared distribution, which includes option income, remained the same going forward. The Distribution Rate is calculated by multiplying an ETF’s Distribution per Share by twelve (12), and dividing the resulting amount by the ETF’s most recent NAV. The Distribution Rate represents a single distribution from the ETF and does not represent its total return. Distribution includes an estimated 29% Return of Capital ("ROC"). The ROC percentage indicates the percentage of the distribution that reflects an investor's initial investment.

Management Fees

This table describes the fees and expenses that you may pay if you buy, sell, and hold shares of the Fund. Investors purchasing or selling shares of the Fund in the secondary market may be subject to costs (including customary brokerage commissions) charged by their broker. The fee table located in the prospectus and updates in prospectus supplements prevail.

Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
Management Fees0.50%
Distribution and Service (12b-1) Fees0.00%
Other Expenses0.00%
Acquired Fund Fees and Expenses10.01%
Total Annual Fund Operating Expenses0.51%

1. Acquired Fund Fees and Expenses are the indirect costs of investing in other investment companies. The operating expenses in this fee table do not correlate to the expense ratio in the Fund’s financial highlights because the financial statements include only the direct operating expenses incurred by the Fund. 

Fund Performance (Total Return)

As of 10/31/2025 09/30/2025

Monthly Quarterly Annually
Cumulative 1 Month 3 Month 6 Month YTD 1 Year Since Inception
NAV 5.16% 14.68% 12.74% 12.87% 5.33% 36.42%
Market Price 5.27% 14.74% 13.03% 13.10% 5.41% 37.03%
Annualized 1 Year 3 Year Since Inception
NAV 5.33% 9.19% 7.94%
Market Price 5.41% 9.23% 8.06%
Cumulative 1 Year Since Inception
NAV -2.83% 29.73%
Market Price -2.88% 30.17%
Annualized 1 Year 3 Year 5 Year Since Inception
NAV -2.83% 10.83% — 6.76%
Market Price -2.88% 10.81% — 6.85%
Calendar Year NAV Market Price
2024 8.87% 8.81%
2023 3.75% 3.84%
2022 -4.27% -4.44%
2021 — —
The performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.

NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.

Market Price: The current price at which shares are bought and sold. Market returns are based upon the last trade price.

Growth of $10,000

The Growth of $10,000 chart reflects a hypothetical investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted. Results are not indicative of future performance. 

Historical Premium/Discount

Calendar Year 2024 3rd Quarter of 2025
Days Traded at Premium
144
32
Days Traded at Discount
108
32
The above frequency distribution chart presents information about the difference between the daily market price for shares of the Fund and the Fund's reported Net Asset Value. The amount that the Fund's market price is above the reported NAV is called the premium. The amount that the Fund's market price is below the reported NAV is called the discount. The market price is determined using the midpoint between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund's NAV is calculated (usually 4:00 p.m. EST). The horizontal axis of the chart shows the premium or discount expressed in basis points. The vertical axis indicates the number of trading days in the period covered by the chart. Each bar in the chart shows the number of trading days in which the Fund traded within the premium/discount range indicated.

Portfolio Holdings

As of 11/12/2025

Holdings - All ETFs
Ticker Name Quantity Weight
MSOS ADVISORSHA PURE US CANNCRB NLUK RES 680,153 1.11%
ABBV ABBVIE INC USD 0.01 56,413 4.99%
ABT ABBOTT LABS NPV 17,018 0.83%
ABVX ABIVAX SA EUR 0.01 ADR 51,151 2.01%
AGL AGILON HEALTH INC USD 0.01 174,456 0.04%
ALHC ALIGNMENT HEALTHCARE INC USD 0.001 209,594 1.32%
AMGN AMGEN INC USD 0.0001 48,600 6.20%
APLS APELLIS PHARMACEUTICALS USD 0.0001 163,588 1.24%
ARGX ARGENX SE EUR 0.1 ADR 2,499 0.84%
ARQT ARCUTIS BIOTHERAPEUTICS USD 0.0001 86,724 0.77%
AZN ASTRAZENECA PLC NPV ADR 56,579 1.88%
BHVN BIOHAVEN LTD NPV 167,855 0.51%
BMY BRISTOL MYERS SQUIBB CO USD 0.1 911 0.02%
BNTC BENITEC BIOPHARMA INC NPV 120,515 0.61%
BSX BOSTON SCI COM USD0.01 12,392 0.49%
CDTX CIDARA THERAPEUTICS INC USD 0.0001 97,343 3.95%
CHWY CHEWY INC USD 0.01 11,162 0.14%
CI CIGNA GROUP USD 0.01 2,691 0.28%
COO COOPER COS INC USD 0.1 10,868 0.30%
CVS CVS HEALTH CORPORATION USD 0.01 128,155 3.90%
DHR DANAHER CORP USD 0.01 35,405 2.95%
EMBC EMBECTA CORP USD 0.01 2,415 0.01%
ESTA ESTABLISHMENT LABS HOLDINGS USD 1.0 58,108 1.39%
EW EDWARDS LI COM USD1 15,409 0.50%
EYE NATIONAL VISION HLDGS INC USD 0.01 1,560 0.01%
EYPT EYEPOINT PHARMACEUTICALS I USD 0.01 138,425 0.63%
FLR FLUOR CORP NEW USD 0.01 5,077 0.09%
FULC FULCRUM THERAPEUTICS INC USD 0.001 127,334 0.40%
GEHC GE HEALTHCARE TECHNOLOGIES USD 0.01 43,094 1.23%
GH GUARDANT HEALTH INC USD 0.00001 22,846 0.85%
GILD GILEAD SCIENCES INC USD 0.001 110,033 5.15%
HQY HEALTHEQUITY INC USD 0.0001 48,266 1.84%
ICLR ICON PLC EUR 0.06 1,247 0.08%
INSM INSMED INC USD 0.01 28,149 2.08%
IQV IQVIA HLDGS INC USD 0.01 13,874 1.16%
ISRG INTUITIVE SURGICAL INC USD 0.001 11,735 2.55%
JAZZ JAZZ PHARMACEUTICALS PLC USD 0.0001 18,718 0.97%
JNJ JOHNSON + JOHNSON USD 1.0 17,492 1.29%
LIVN LIVANOVA PLC GBP 1.0 14,836 0.32%
LLY LILLY ELI + CO NPV 19,723 7.61%
LPTX LEAP THERAPEUTICS INC NPV 1,492,943 1.16%
MLYS MINERALYS THERAPEUTICS I USD 0.0001 334,751 6.01%
MMM 3M CO USD 0.01 2,714 0.18%
NBIX NEUROCRINE BIOSCIENCES IN USD 0.001 20,755 1.16%
NKTR NEKTAR THERAPEUTICS USD 0.0001 158,451 3.47%
PCRX PACIRA BIOSCIENCES INC USD 0.001 68,781 0.62%
PCT PURECYCLE TECHNOLOGIES I USD 0.0001 903,824 3.29%
PEN PENUMBRA INC USD 0.001 12,406 1.32%
PRAX PRAXIS PRECISION MEDICIN USD 0.0001 309 0.02%
REGN REGENERON PHARMACEUTICALS USD 0.001 19,290 4.99%
RVTY REVVITY INC USD 1.0 25,133 0.90%
SNDX SYNDAX PHARMACEUTICALS I USD 0.0001 43,625 0.28%
SRPT SAREPTA THERAPEUTICS INC USD 0.0001 6,324 0.04%
SYK STRYKER CORP USD 0.1 1,872 0.26%
TFX TELEFLEX INC USD 1.0 1,171 0.05%
TGTX TG THERAPEUTICS INC USD 0.001 17,615 0.21%
TMO THERMO FISHER SCIENTIFIC IN USD 1.0 3,695 0.82%
TXG 10X GENOMICS INC USD 0.00001 387,492 2.45%
UNH UNITEDHEALTH GROUP INC USD 0.01 21,930 2.82%
UTHR UNITED THERAPEUTICS CORP D USD 0.01 18,986 3.32%
VLTO VERALTO CORP USD 0.01 642 0.02%
VRTX VERTEX PHARMACEUTICALS INC USD 0.01 13,950 2.30%
ZBH ZIMMER BIOMET HLDGS INC USD 0.01 3,574 0.12%
- Estimated Cash 4,387,543 1.66%

Holdings are subject to change without notice.

Recent Distributions

Ex-Dividend Date Record Date Payable Date Total Distribution
N/A
$0.05000
$0.05000
$0.05000
$0.01353
View Distribution History
S19(a) Notices Data in the s19 reports should not be relied upon to estimate the tax classification of distributions. They are rough point-in-time estimates that do not line up with the fund's fiscal year end and are thus not reflective of the tax information investors should expect. S19 reports are posted for regulatory requirements only.
S19(a) Notices Close
Data in the s19 reports should not be relied upon to estimate the tax classification of distributions. They are rough point-in-time estimates that do not line up with the fund's fiscal year end and are thus not reflective of the tax information investors should expect. S19 reports are posted for regulatory requirements only.

Why Register?

  • In-depth case studies provide valuable insights into practical portfolio problems and their solutions
  • Simplify curated model portfolios that show investors how to incorporate alternatives into their portfolio
Create Your Account
Simplify Curated Model Portfolios Incorporating Alternatives In-Depth Case Studies To Help You Manage Portfolios
Contact Us